The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

24 Jun 2019 15:10

RNS Number : 2342D
WideCells Group PLC
24 June 2019
 

24 June 2019

WideCells Group PLC ("WideCells" or the "Company")

Notice of General Meeting and Proposed Change of Name to Iconic Labs PLC

 

WideCells Group PLC announces that it is proposing to change the name of the Company to "Iconic Labs PLC", which is more appropriate for the Company's new business strategy, and to adopt new articles of association.

 

Resolutions to change the name of the Company and to adopt the new articles of association, in substitution for and to the exclusion of the existing articles of association, will be proposed at a General Meeting ("GM") to be held at the offices of finnCap, 60 New Broad St, London EC2M 1JJ at 11.00am on Wednesday 10 July 2019.

 

Iconic Labs is a new media and technology business, which is focused on providing online marketing, content and technology-driven products. The Company, which is led by John Quinlan and Liam Harrington, who were founders and key drivers behind UNILAD, the world's largest social media publisher, has successfully tried, tested and soft launched its initial media and advertising focused agency model.

 

Since the team joined the Company in March 2019, it has made strong progress in establishing its offering and building out its presence within the new media marketing space.

 

A notice of the GM setting out full details of the name change has been posted to shareholders and will shortly be available on the Company's website: www.iconiclabs.co.uk 

 

Executive Chairman, David Sefton, said: "We have made excellent progress in restructuring the business which, when complete and combined with the approval of the proposed name change, will enable us to direct our energies towards a formal launch of Iconic Labs and the realisation of its full potential.

 

"The soft launch of the Company has already got off to a promising start - earlier this month, we commenced work on a consulting and marketing services engagement with a UK-based financial services business (see RNS dated 3 June 2019). This engagement is on a long-term retainer basis, with initial revenues over the first year expected to exceed £1 million, with the potential for material increases.

 

"I look forward to building on this initial traction through winning further contracts and establishing Iconic Labs as a trailblazer for offering marketing services at the cutting-edge of technology and embracing change to create new products, while at the same time, remaining focused on our cash-flow driven business model and delivering value for shareholders."

Chief Executive Officer, John Quinlan, said: "We are hugely excited to be approaching the official launch of Iconic Labs and have been working hard behind the scenes to ensure that we are ready to hit the ground running.

 

"We have received considerable interest to date and are confident that the new business and acquisition pipeline already generated is set to grow rapidly as we broaden the commercial marketing strategy of the Company.

 

"We have an aggressive growth strategy, including making targeted acquisitions, and in the short-term we remain focused on establishing a solid client base of forward-thinking companies keen to embrace change and technology to improve their direct to consumer and marketing approach."

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Shard Capital Partners LLP

Co-broker - Damon Heath, Erik Woolgar

Tel: +44 (0) 20 7186 9950

finnCap Ltd

St Brides Partners Limited

Co-broker - Chris Raggett, Scott Mathieson

PR - Melissa Hancock, Juliet Earl

Tel: +44 (0) 20 7220 0500

Tel: +44 (0) 20 7236 1177

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGZZLFLKQFBBBF
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.